Huntington SF, Schuster SJ, Ding W, Koehler AB, et al. DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study. Am J Hematol 2023;98:739-749.
PMID: 36810799